News
As A Rapid Response, ViiV Creates A $500,000 Monkeypox Fund
In a press statement, ViiV Healthcare stated that the Monkeypox Emergency Response Fund would be distributed to U.S. community-based organisations.
ViiV, which has a strong...
Drug Research
Hanmi Brings Back Liver Drug After Raising Its Efficacy
After leveraging its microemulsion technology to increase the absorption rate and so address a shortcoming of the original formulation, Hanmi Pharmaceutical has reintroduced its...
Clinical Trials
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma
Bristol Myers Squibb and 2seventy bio, Inc.announced positive topline results from KarMMa-3, a Phase 3, global, randomized, multicenter, open-label study evaluating Abecma (idecabtagene vicleucel)...
Drug Research
West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms
West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch...
Press Releases
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner, SK bioscience, has received a...
Press Releases
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Roche announced that the US FDA has approved a supplemental New Drug Application (sNDA) for Xofluza® (baloxavir marboxil) for the treatment of acute uncomplicated...
Drug Research
Thermo Fisher Announced FDA Approves First NGS-Based Companion Diagnostic to Aid in Selecting Non-Small C
The U.S. FDA has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read